<![CDATA[Chugai Pharmaceutical: News Releases]]> https://www.chugai-pharm.co.jp/english/index.html en-us Tue, 27 Oct 2026 17:00:00 +0900 <![CDATA[Chugai Announces 2026 3rd Quarter Results]]> https://www.chugai-pharm.co.jp/english/news/detail/20261027170000_1297.html Tue, 27 Oct 2026 17:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20261027170000_1297.html <![CDATA[Roche's Announcement Regarding divarasib (Presentation of Latest Data in KRAS G12C-Positive Non-Small Cell Lung Cancer at ESMO)]]> https://www.chugai-pharm.co.jp/english/news/detail/20261026120000_1295.html Mon, 26 Oct 2026 12:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20261026120000_1295.html <![CDATA[Roche’s Announcement Regarding Sefaxersen (Detailed Interim Analysis Data from the Phase III IMAgINATION Study)]]> https://www.chugai-pharm.co.jp/english/news/detail/20261026163000_1296.html Mon, 26 Oct 2026 16:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20261026163000_1296.html <![CDATA[F. Hoffmann-La Roche Announces Third Quarter Sales 2026]]> https://www.chugai-pharm.co.jp/english/news/detail/20261022143000_1293.html Thu, 22 Oct 2026 14:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20261022143000_1293.html <![CDATA[Chugai Receives Porter Prize 2026]]> https://www.chugai-pharm.co.jp/english/news/detail/20261016190000_1291.html Fri, 16 Oct 2026 19:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20261016190000_1291.html <![CDATA[Roche’s Announcement Regarding Enspryng (FDA Approval for Thyroid Eye Disease)]]> https://www.chugai-pharm.co.jp/english/news/detail/20261016153000_1294.html Fri, 16 Oct 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20261016153000_1294.html <![CDATA[Roche's Announcement Regarding Vamikibart (1 Year Data in Uveitic Macular Edema) ]]> https://www.chugai-pharm.co.jp/english/news/detail/20261013113000_1292.html Tue, 13 Oct 2026 11:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20261013113000_1292.html